Dr. David Fink

Biography

David Fink, PhD, MPH, is a substance use psychiatric epidemiologist whose research broadly aims to develop and apply rigorous causal inference methodologies to study the causes of addiction and mental illness. He has a particular focus on estimating the effects of federal and state policies and programs. His research on mental health, substance use, and health policy is driven by a desire to understand and reshape the structural, societal, and interpersonal factors that influence health and well-being throughout the life course. David received his Master's in Public Health from San Diego State University with a focus on epidemiology and biostatistics and earned his PhD in Epidemiology from Columbia University. His research has investigated the effects of cannabis legalization and prescription drug monitoring programs on drug-related morbidity and mortality. Currently, he works as an assistant professor in the Department of Internal Medicine at Yale University, where he is funded by the National Institute on Drug Abuse (NIDA) to explore the impacts of flexible telehealth guidelines on buprenorphine prescribing for opioid use disorder.

Research Interests

Experience